Navigation Links
Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
Date:6/4/2008

is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals,

Eric Rosenberg,

Cell: +972-54-566-7713,

Office: +972-2-566-0001,

Email: eric@oramed.com .

Media Contacts:


'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
2. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
3. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
4. Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
5. VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
6. Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008
7. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
8. Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
9. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
10. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
11. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 New interactive ... innovative thought leaders of the medical device industry ... conference and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These ... industry professionals practical presentations and implementable solutions on ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Men’s skin is ... La-roche Posay ) and has been known to react ... some men may be far from puberty, other acne causing ... pores, causing breakouts, and threatening skin with unsightly acne scars. ... from Men’s Health on how to reduce and ...
(Date:5/17/2013)... Tooth decay is an epidemic in American children ... disease. The World Health Organization says that worldwide, 60–90% ... cavities. What are the long-term effects of this transmissible infection? ... between the oral bacterial imbalance and serious systemic issues like ... it is also 100% preventable? Answer: there has been no ...
(Date:5/16/2013)... 2013 A new selection of ... Cole-Parmer is designed to meet the dynamic needs ... The new Cole-Parmer® MS-3400 Centrifuges are ... lab. They ensure a powerful and complete separation ... Their standard four-place swinging buckets hold 50-mL tubes. ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3Cole-Parmer Offers Enhanced Selection of Centrifuges 2
... ... Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and ... , ... (PRWEB) May 18, 2010 -- The era of Personalized Medicine is set to revolutionize ...
... 18, 2010 Among more than 5000 poster,abstracts, Aprea AB has ... Oncology (ASCO) Meeting in Chicago . The,presentation will describe the scientific ... candidate APR-246. , , , ... Aprea,s drug candidate APR-246 belongs to a new class of ...
... NINGBO, China , May ... Ltd. (TAIJI),s FGD (Flue-gas desulfurization),technology was officially put into ... project, TAIJI chose to use steel slag as an ... desulfurization. In,comparison to the use of lime agents, the ...
Cached Biology Technology:Arrowhead Releases New Report Assessing State of Personalized Medicine Market 2Arrowhead Releases New Report Assessing State of Personalized Medicine Market 3Aprea to Present Phase I/II Trial Design 2Aprea to Present Phase I/II Trial Design 3TAIJI Announces Official Operation of Its Sintering FGD Project for Tangshan 2
(Date:5/17/2013)... The State University of New Jersey, and City University ... called Visikol TM that effectively clears organisms to ... place of chloral hydrate, which is one of the ... tightly regulated by the Drug Enforcement Administration (DEA) due ... or clearing agents, are vital for viewing organisms under ...
(Date:5/17/2013)... Why Tibetan antelope can live at elevations of ... research published in Nature Communications , investigators ... evidence that some genetic factors may be associated ... The data in this work will also provide ... biology of other ruminant species. , The Tibetan ...
(Date:5/17/2013)... American Societies for Experimental Biology (FASEB) released a new ... funding trends highlighting the devastating impact of sequestration on ... analysis follows a May 15th Senate Appropriations Committee hearing ... that the $1.6 billion cut the agency sustained in ... impact on the scientific community." , According to ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3The genome sequence of Tibetan antelope sheds new light on high-altitude adaptation 2
... Yi Li,s Laboratory in the University of Connecticut,s ... seedless variety of the popular ornamental shrub Euonymus ... the plant,s brilliant foliage yet eliminates its ability to ... a triploid seedless, non-invasive variety of burning bush creates ...
... (such as Parkinson,s or post-traumatic medullar injury) are especially difficult ... parts of the neural puzzle which are damaged. The key ... cells but for this it is essential that the support ... the nervous system. This is what biochemist Patricia Garca has ...
... U.S. Departments of Energy and Agriculture have awarded 10 ... the efficiency and cost-effectiveness of growing biofuel and bioenergy ... by the Obama administration to develop domestic renewable energy ... America,s energy needs and creating new opportunities for the ...
Cached Biology News:UConn scientist develops sterile variety of invasive plant 2UConn scientist develops sterile variety of invasive plant 3A mold on which to create new parts of the puzzle that is the nervous system 2USDA and DOE fund 10 research projects to accelerate bioenergy crop production 2
Phospho-C/EBPbeta (Thr235) Antibody...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
... UbcH7 interacts with the ... c-Cbl RING domain. Evidence suggests ... in both the degradation of ... of certain N-a -acetylated proteins ...
Goat polyclonal to Sarcosine Oxidase (HRP) ( Abpromise for all tested applications). Antigen: Full length protein: Sarcosine Oxidase (microbial). Entrez Gene ID: 51268 Swiss Protein ID: ...
Biology Products: